• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevention of fatal pulmonary embolism.

作者信息

Kakkar V V

机构信息

Thrombosis Research Institute, London, UK.

出版信息

Haemostasis. 1993 Mar;23 Suppl 1:42-50. doi: 10.1159/000216908.

DOI:10.1159/000216908
PMID:7684351
Abstract

Venous thromboembolism is a frequent complication in hospitalized patients. A number of drugs are now available to prevent this complication. These include dextron, oral anticoagulants, standard heparin and low-molecular-weight heparin. The efficacy of these drugs is reviewed in this paper. The data presented indicate that a single fixed daily subcutaneous injection of low-molecular-weight heparin provides a simple and an effective method of preventing death due to massive pulmonary embolism. Therefore emphasis should now be on the physicians and surgeons to protect all high-risk patients.

摘要

相似文献

1
Prevention of fatal pulmonary embolism.
Haemostasis. 1993 Mar;23 Suppl 1:42-50. doi: 10.1159/000216908.
2
[Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].低分子量肝素CY 216预防术后静脉血栓栓塞的疗效与耐受性
Med Klin Suppl. 1986 Oct;3:13-6.
3
Effectiveness and safety of the low-molecular-weight heparin CY 216 in the prevention of fatal pulmonary embolism and thromboembolic death in general surgery. A multicentre, double-blind, randomized, controlled clinical trial versus placebo (STEP). STEP Study Group.
Haemostasis. 1990;20 Suppl 1:193-204. doi: 10.1159/000216178.
4
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?静脉血栓栓塞症的治疗:普通肝素还是低分子量肝素?
Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83.
5
[Prevention of postoperative deep vein thrombosis of the lower limbs].[下肢术后深静脉血栓形成的预防]
Klin Khir. 1998(2):38-41.
6
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.一项关于新型第二代低分子肝素(苄丙酮香豆素钠)和普通肝素预防术后静脉血栓栓塞的双盲随机对照试验。苄丙酮香豆素钠评估组。
Thromb Haemost. 2000 Apr;83(4):523-9.
7
The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.低剂量皮下注射肝素和右旋糖酐预防术后深静脉血栓形成和肺栓塞
Surg Gynecol Obstet. 1976 Dec;143(6):981-5.
8
Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.小剂量肝素预防术后致命性肺栓塞。一项国际多中心试验。
Lancet. 1975 Jul 12;2(7924):45-51.
9
Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
Semin Thromb Hemost. 1993;19 Suppl 1:122-7.
10
When can the patient with deep venous thrombosis begin to ambulate?深静脉血栓形成的患者何时可以开始走动?
Phys Ther. 2004 Mar;84(3):268-73.

引用本文的文献

1
Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy.意大利外科手术患者使用那屈肝素钙预防深静脉血栓形成和肺栓塞的经济学评价
Pharmacoeconomics. 1997 Oct;12(4):475-85. doi: 10.2165/00019053-199712040-00005.